Opinions
Peter Hodson
SQI Diagnostics Inc.
SQD-X
COMMENT
Nov 07, 2008
Does rapid testing for clinical diagnostics. Has held in quite well. Going through an approval process and it looks like things will be okay. Leveraged earnings are pretty big. Likes the company but is not actively buying it.
$1.300
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
They did a recent financing which has a high participation from management. Their system allows you to do a more efficient analysis of blood in a lab. They are approaching the large lab diagnostics companies in the US. They continue to evolve the technology and improve it.
biotechnology
pharmaceutical
Advertising